文献速递甲状腺疾病骨质疏松与钙磷/甲状旁腺

甲状腺癌术后永久性甲状旁腺功能减退症的长期并发症:全国性队列研究

Long-Term Morbidity after Postoperative Hypoparathyroidism in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study.
PubMed 文献 · Thyroid · 2026-02-18

该回顾性队列研究利用韩国全国理赔数据,比较甲状腺癌术后永久性甲状旁腺功能减退症(PO-hypoPT)患者与甲状旁腺功能保留者的长期并发症风险。经1:2倾向性评分匹配后纳入15,592例PO-hypoPT患者和27,906例对照,中位随访约5年。结果显示PO-hypoPT与肾结石、肾功能不全和主要不良心血管事件风险升高相关,而癫痫、感染、白内障和抑郁风险无显著差异。

要点

  • 甲状腺癌术后PO-hypoPT患者肾功能不全风险显著升高(HR 1.75)。
  • PO-hypoPT与肾结石(HR 1.17)和MACE(HR 1.10)风险轻度增加相关。
  • 癫痫、感染、白内障和抑郁风险与甲状旁腺功能保留者无显著差异。

核心结论

  • 甲状腺癌术后PO-hypoPT与长期肾脏和心血管并发症风险增加相关。
  • 建议对该人群进行肾功能和心血管健康的长期监测。

研究设计与样本

  • 回顾性队列研究,使用韩国全国理赔数据(OMOP CDM)。
  • 2013至2020年接受甲状腺切除术的217,156例甲状腺癌患者中,经1:2倾向性评分匹配后纳入15,592例PO-hypoPT患者和27,906例对照。

主要发现

  • 癫痫、感染、白内障和抑郁风险在两组间无显著差异。
  • PO-hypoPT与肾功能不全的关联在性别、年龄和钙剂补充时长各亚组中一致。

临床怎么用

  • 对甲状腺癌术后永久性甲状旁腺功能减退症患者应长期监测肾功能。
  • 关注该人群的心血管健康,警惕MACE风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic hypoparathyroidism (hypoPT) is associated with various systemic morbidities; however, its impact in thyroid cancer patients following thyroidectomy remains unclear. This study evaluated the risk of long-term morbidities in thyroid cancer patients who developed permanent postoperative hypoparathyroidism (PO-hypoPT), compared to those with preserved parathyroid function. METHODS: This was a retrospective cohort study using South Korea's nationwide claims data encoded in the Observational Medical Outcomes Partnership Common Data Model. Among 217,156 thyroid cancer patients who underwent thyroidectomy from 2013 to 2020, 15,592 patients with PO-hypoPT and 27,906 matched controls with preserved parathyroid function were identified after 1:2 propensity score (PS) matching. Long-term morbidities associated with hypoPT included nephrolithiasis, renal insufficiency, major adverse cardiac events (MACE), seizures, infections, cataracts, and depression. Hazard ratios (HRs) for these morbidities were estimated using Cox proportional hazards regression analysis after large-scale PS matching. RESULTS: The median follow-up duration in both groups was approximately 5 years. Patients with PO-hypoPT had a significantly higher risk of nephrolithiasis (HR 1.17, confidence interval [CI] 1.04-1.30), renal insufficiency (HR 1.75, [CI 1.50-2.03]), and MACE (HR 1.10, [CI 1.01-1.19]) compared to those with preserved parathyroid function. However, the risks of other long-term morbidities, including seizures, infections, cataracts, and depression, were not significantly different between the two groups. The association between PO-hypoPT and renal insufficiency remained consistent across all subgroups stratified by sex, age, and duration of calcium supplementation. CONCLUSIONS: PO-hypoPT in thyroid cancer patients is associated with increased long-term morbidity, particularly renal and cardiovascular complications. Long-term monitoring of renal function and cardiovascular health is warranted in this population.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ahn SH, Seo SH, Jung CY, et al. Long-Term Morbidity after Postoperative Hypoparathyroidism in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study. Thyroid. 2026. PMID: 41705866. doi:10.1177/10507256261425690

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。